Skip to main content
Premium Trial:

Request an Annual Quote

Leo Pharma Taps Intomics for Data Services

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Bioinformatics contract research firm Intomics will provide its services to Leo Pharma for early drug discovery applications, Intomics said today.

A recent spin-off from The Danish Technical University, Intomics will provide data mining and analysis services for a range of Leo Pharma's research projects.

An independent company owned by the Leo Foundation, Leo Pharma is focused on developing drugs for dermatology and critical care applications, including treatments for psoriasis and other skin diseases, as well as thromboembolisms.

Financial terms of the agreement were not released.